Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Why Are Clinical Trials Not Typically a Care Option?

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio


Follow This Show

If you liked this show, you should follow Pharma Talk Radio.

Murray Abramson, MD, VP Clinical Operations, Biogen and Jeff James, CEO, Wilmington Health, discuss the blockers and enablers to making clinical research a care option. Discuss includes:

  • What are the blockers or conflicts (laws, culture, behaviors, etc) that prevent clinical research from becoming a care option?
  • What is the difference between a movement and an initiative - how should be think about clinical research as a care option? Benefits?
  • What are the enablers or requirements to incorporate clinical research into care options for the patient?
  • How to pave a path for possibility
  • Update on data to support how trials can be a care option

This discussion was held at the Clinical Research as a Care Option (CRAACO) meeting held April 11, 2018 in Cambridge, MA.

The 2019 CRAACO meeting will take place April 29-30 in Raleigh-Durham, NC. Find out more here.